Cancer Vaccinology and Preventive Vaccines

Cancer Vaccinology and Preventive Vaccines focus on developing vaccines that either prevent cancer or stimulate the immune system to fight existing cancer cells. Preventive vaccines are designed to protect against viruses known to cause cancer, such as the HPV vaccine (human papillomavirus), which helps prevent cervical, throat, and other cancers, or the Hepatitis B vaccine, which reduces the risk of liver cancer. Cancer vaccinology also explores therapeutic vaccines aimed at treating existing cancers by stimulating the immune system to target and destroy tumor cells. These vaccines are personalized to recognize specific cancer antigens and can be used in combination with other cancer treatments, offering a promising avenue for both cancer prevention and treatment.

    Related Conference of Cancer Vaccinology and Preventive Vaccines

    November 25-26, 2024

    7th International Conference on Anti-Cancer Drugs & Therapies

    Vancouver, Canada
    November 28-29, 2024

    14th World Congress on Breast Cancer

    Paris, France
    December 10-11, 2024

    8th Global Meeting on Oncology and Radiology

    Dubai, UAE
    December 11-12, 2024

    34th Experts Meet On Cancer Research & Therapy

    Paris, France
    December 12-13, 2024

    44th Euro Congress on Cancer Science & Therapy

    Rome, Italy
    March 10-11, 2025

    3rd World Congress on Oral Cancer

    Paris, France
    March 24-25, 2025

    25th World Congress on Cancer and Diagnostics

    London, UK
    March 24-25, 2025

    10th World Conference on Breast and Cervical Cancer

    Paris, France
    June 16-17, 2025

    26th World Congress on Cancer Summit

    Amsterdam, Netherlands

    Cancer Vaccinology and Preventive Vaccines Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in